Cardiovascular Medicine

Ravi Shah, MD, the Gottlieb C. Friesinger II Professor of Cardiovascular Medicine and professor of Medicine, has been named co-director of the Vanderbilt Diabetes Center (VDC).

In a study that brings together genetics, gene expression and blood biomarkers, investigators have built a framework for exploring multiorgan cross talk in human health and disease.

According to a study recently published in the Journal of the American College of Cardiology, a patient-reported outcome measure (PROM) for adults with heart failure reliably predicted hospitalizations and mortality and outperformed all other electronic health record variables.

Faced with great challenge and uncertainty, those who make up the department’s faculty have remained true to their mission and completed “outstanding, life-saving work,” Dr. Freedman said.

Amanda Doran, MD, PhD (Cardiovascular Medicine), is corresponding author of the paper, which was published last month in the American Heart Association's journal, Arteriosclerosis, Thrombosis and Vascular Biology.

Evan Brittain, MD, MSCI (Cardiovascular Medicine), is corresponding author of a study recently published in JAMA Network Open that reported that U.S. veterans with depression had a 14% higher risk of heart failure, even after adjusting for traditional risk factors.

For the first time, a Vanderbilt Health patient has been implanted with a novel left atrial pressure monitoring device (the V-LAP device), part of a clinical trial being conducted at only five centers in the United States.